Spencer Pharmaceutical to Announce Material Event Before Market Opens Friday, December 10, 2010
09 Dezembro 2010 - 7:05PM
Marketwired
Spencer Pharmaceutical Inc. (PINKSHEETS: SPPH) announced today
after the markets closed that it will be announcing a material
event before the market opens Friday, December 10, 2010.
About Spencer Pharmaceutical Inc. Spencer
Pharmaceutical Inc. is a US-based Pharmaceutical Research and
Development Corporation, which is developing innovative drug
release and absorption systems for the treatment of metabolic
diseases such as diabetes and metabolic syndrome.
Important Information About Forward-Looking Statements in this
press release may be "forward-looking statements" within the
meaning of the Private Securities Litigation Reform Act of 1995.
Words such as "anticipate," "believe," "estimate," "expect,"
"intend" and similar expressions, as they relate to the company or
its management, identify forward-looking statements. These
statements are based on current expectations, estimates and
projections about the company's business based, in part, on
assumptions made by management. These statements are not guarantees
of future performance and involve risks, uncertainties and
assumptions that are difficult to predict. Therefore, actual
outcomes and results may, and probably will, differ materially from
what is expressed or forecasted in such forward-looking statements
due to numerous factors, including those described above. In
addition, such statements could be affected by risks and
uncertainties related to the exploration for and development of
mineralized material, product demand, market and customer
acceptance, competition, pricing and development difficulties, as
well as general industry and market conditions and growth rates and
general economic conditions. Any forward-looking statements speak
only as of the date on which they are made, and the company does
not undertake any obligation to update any forward-looking
statement to reflect events or circumstances after the date of this
release. Information on the Company's website does not constitute a
part of this release.
Contact: Dr. Max Arella President Spencer Pharmaceutical
Inc. Tel. 1+(617) 973-5017
Spencer Pharmaceutical (CE) (USOTC:SPPH)
Gráfico Histórico do Ativo
De Ago 2024 até Set 2024
Spencer Pharmaceutical (CE) (USOTC:SPPH)
Gráfico Histórico do Ativo
De Set 2023 até Set 2024
Notícias em tempo-real sobre Spencer Pharmaceutical Inc (CE) da OTCMarkets bolsa de valores: 0 artigos recentes
Mais Notícias de Spencer Pharmaceutical Inc.